BioCentury
ARTICLE | Clinical News

SPC3 synthetic multi-branched peptide containing eight repeats of the consensus region of the V3 loop: Began Phase II/III trial in the U.K.; a U.S. IND will be

February 27, 1995 8:00 AM UTC

Columbia Laboratories Inc. (COB), Miami Product: SPC3 synthetic multi-branched peptide containing eight repeats of the consensus region of the V3 loop, intended to block entry of HIV into cells Indica...